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Objectives: The aim of this study was to identify domains that determine quality of life in patients with 
peripheral arterial disease (PAD) and find the patient reported outcome measures (PROMs) that can 
examine the identified themes.  
Methods: A systematic review of all the main six databases was undertaken to identify primary 
qualitative studies reporting on PAD patients’ health and/or quality of life.  Quality of studies was 
assessed using the CASP criteria. Findings from the included studies were analysed using 
Framework Analysis methodology. The identified themes were mapped against the items/domains of 
validated patient reported outcome measures (PROMs) used in patients with PAD.  
Results: 
The systematic review identified eight papers that fulfilled the inclusion criteria. The included papers 
reported the views of 186 patients with PAD including patients with intermittent claudication, critical 
ischaemia and amputation secondary to PAD.. The overall quality of the included studies was good 
based on CASP criteria.  Framework Analysis identified thirty-five themes that were divided into six 
main groups: symptoms, impact on physical functioning, impact on social functioning, psychological 
impact, financial impact and process of care.. The best fit generic and disease specific PROMs were 
Nottingham health profile (NHP) and Vascular quality of life questionnaire (VascuQoL) respectively. 
None of the PROMs covered all the themes important to patients with PAD.  
Discussion:  
The findings from the review identified the important domains that affect patients living with PAD None 
of the current generic and disease specific PROMs provide a comprehensive measure for all themes 




- Peripheral arterial disease is a spectrum of conditions ranging from asymptomatic disease 
and minor claudication to limb loss.  
- Understanding and measuring quality of life in these patients is of paramount importance to 
guide intervention. 
- This systematic review is the most comprehensive attempt in measuring the impact of this 
disease in its different manifestation and can help improve current measures that are used to 
measure quality of life.   
Introduction 
 
Population studies suggest that 1 in 5 people above the age of 60 have some degree of peripheral 
artery disease (PAD) in the lower limbs. The incidence of this disease increases with age (1). Most 
patients with PAD are asymptomatic however patients can present with a spectrum of symptoms, 
reflecting different stages of the disease. The most common clinical presentation is intermittent 
claudication (IC), which is pain in the leg on walking; only 20% of these patients develop severe 
symptoms of critical limb ischaemia (CLI) (2). Patients with CLI can present with rest pain, non-
healing leg ulcers or gangrene; if they do not receive treatment they may lose part of their lower limbs 
(3,4). Patients with CLI have a high risk of mortality with nearly 25% dying and 30% requiring major 
lower limb amputation within one year (5,6). Symptomatic PAD results in significant functional 
limitations and reduced health-related quality of life (HRQoL) in affected patients (5).  
PAD is a chronic disease and patients suffering with this condition need support to choose the best 
treatment strategy to reduce the impact on their quality of life. HRQoL can be measured using either 
generic or disease specific patient reported outcome measures (PROMs). Patient choice over 
treatment and care is a central feature of most advanced health care systems, it is proposed that 
information gathered by PROMs from patients directly can help inform the choice of treatments and 
promote equity as well as excellence (7).  
Patients' experience of treatment and care is a major indicator of quality and there has been a huge 
expansion in the development and application of PROMs. These instruments examine the most 
important issues to the patients by asking them directly about any changes. PROMs provide an 
insight into the way patients perceive their health and the impact that treatments have on their quality 
of life.  
The aim of this study was to systematically review the qualitative evidence of people’s experiences of 
living with PAD. The identified domains were then mapped against the items/domains of identified 
validated generic and disease specific PROMs (8). The intention was to find the PROMs that captured 
the most important issues to patients with PAD.  
Method 
The review aimed to find all the primary qualitative research studies (interview and/or focus groups) 
that explicitly investigated the impact of PAD on daily living, health and quality of life. The inclusion 
criteria included any patients with PAD (IC, CLI, ischaemic ulceration, necrosis, gangrene and 
amputation due to PAD).  Any studies with undefined population or mixed population that included the 
views from patients not suffering with PAD were excluded.  
For further information regarding the inclusion and exclusion criteria refer to table 1.  
This systematic review was undertaken and reported in accordance with the general principles 
recommended in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement. In accordance with the study protocol 
(https://www.sheffield.ac.uk/polopoly_fs/1.552397!/file/DP_16_05.pdf) (9), searches were conducted 
from inception up to April 2017 in bibliographic databases including CINAHL via EBSCO, Medline and 
Medline in Process via Ovid, Embase via Ovid, PsycINFO via Ovid, Social Science Citation Index/ 
Science Citation Index via Web of Science (Thomson Reuters) and Proquest dissertations and 
theses. No language or date constraints were applied.  
 Insert Table 1 
 
The search strategy combined condition terms, terms for patient views and terms for qualitative 
studies (which augmented a qualitative study filter) (9). Further details of the search strategy are 
provided in Appendix 1 (supporting information).  
 
Study selection 
The search results were entered into Endnote X8™ (Thomson Reuters, Philadelphia, USA), two 
reviewers (AA, PP) independently screened the titles for inclusion and exclusion in accordance with 
the set criteria in the protocol. All titles were examined, and any citations that clearly did not meet the 
inclusion criteria (for example mixed population, quantitative PROMs data, unrelated to PAD) were 




The Critical Appraisal Skills Program (CASP) qualitative checklist instrument was used to assess the 
methodological quality of the included studies in the review (10). This was selected as it assesses 
both the appropriateness and the quality of reporting of the studies included and is commonly used in 
qualitative reviews of evidence (11). CASP consists of ten questions about the qualitative 
methodology that are answered either as yes, no or unclear. Two of the authors (AA, EL) 
independently examined the quality of each study and any inconsistencies were resolved by 
discussion or involving a third author (GJ).   
 
Data extraction and analysis 
The data on authors, year of publication, country of study, number of participants, research aims, 
methods of recruitment, method of data collection, key results and analysis were extracted and 
tabulated for all the included studies. The first author (AA) uploaded all the papers into the qualitative 
data analysis software NVIvo10 (QSR International, Doncaster, Victoria, Australia) and the primary 
and secondary text (patient quotes reported in the articles and themes), were analysed. Framework 
Analysis was used to identify common and variable themes within the text of each article (12). The 
first stage of the analysis was undertaken by reading all the included papers to identify common terms 
and themes from within and across the articles. The second stage involved identifying a thematic 
framework by creating an initial coding scheme for the main themes; and eventually creating an index 
of themes. In the third stage the thematic framework was applied to all the primary and secondary 
data in the included papers. A framework matrix was created to arrange the data per the thematic 
references in the fourth stage. In the fifth and final stage themes were examined for their conceptual 
similarities and differences (Mapping and interpretation stage). A second reviewer (EL) checked all 
the themes that were identified and differences in conceptualization were discussed and adjusted. 
 
Triangulation of PROMs items with qualitative themes 
To examine the extent to which the items within generic and PAD disease specific PROMs 
corresponded to themes from the qualitative review a triangulation approach was followed (13,14).  
The items from generic and disease specific PROMs validated in patients with PAD (8) were 
examined in detail. The items from these instruments were mapped against the themes identified, and 
two researchers(AA, EL) reviewed both the themes from the qualitative review and the PROM 
items/domains to evaluate whether the concepts were the same (agreement), offered similar concepts 
(partial agreement) or were not present (silence). The aim was to identify whether any of the 




The database searches identified 1113 citations; after removing duplicates, 779 titles were assessed 
and subsequently 65 full-text papers were reviewed in detail. Finally, only 8 papers fulfilled the 
inclusion criteria and were included in the qualitative evidence synthesis (Please see PRISMA chart 
(Figure 1)). Characteristics and main findings of the studies included in the qualitative synthesis are 
summarized in table 2.  
Insert Table 2 
Two of the studies were conducted in the UK (15, 16), three in Sweden (17-19) and three in the 
United States (20-22). The studies were published between 1998 and 2015; the mean age of the 
participants in the included studies ranged from 64-77, and the percentage of male participants was 
50-79%. The included studies reported the views of 186 patients with PAD including patients with 
intermittent claudication (IC), critical limb ischaemia (CLI) and amputation of lower limbs due to PAD.  
 
Quality assessment  
The overall quality of the included studies was good and all the studies scored “yes” for almost all the 
criteria set in the CASP checklist (10); however, four studies scored “can’t tell” regarding 
consideration of the relationship between participants and researcher (16, 19-21). Only one study 
scored ‘can’t tell’ when assessing if the recruitment strategy was appropriate to the aims of the 
research (20). For further detail on the quality of the included studies please see appendix 2. 
Analysis  
The Framework Analysis of the primary and secondary data in the included papers identified six main 
issues including symptoms, physical functioning, impact on social functioning, psychological impact, 
financial impact and process of care. In total thirty-five themes were identified. Table 3 shows the 
themes and subthemes and the sources from the included papers in this review.  
Insert Tables 3  
Symptoms 
 
This theme included several subthemes such as pain, altered sensation, cold extremities, weakness, 
mobility, ulcers, sexual functioning and symptom progression.  
Pain 
 
This was identified in all the included papers, severity of the disease resulted in different experiences 
of pain and this was reflected in the pain subthemes.  
Patients described different experiences with the initial appearance of the symptoms. Pain was most 
commonly described as discomfort, ache, cramp and creeping feelings of fatigue that got worse the 
farther they walked.  
“I get a cramping in the left calf.” “My legs get tired. I can feel it in my thighs.” (21) 
“I get this terrible cramp in my legs and then I don’t know where to go.” (17) 
The description of pain in the legs and feet was different for patients with CLI. Some of these patients 
described rest pain and burning sharp pain in their feet and legs. Patients with vascular related 
amputation described the same type of continuous rest pain prior to their amputation.  
 
“If I could, I would have taken an axe and chopped off my leg sooner just to get rid of the pain “ 
“When asked, 85% of patients felt that intolerable ischemic rest pain is the most appropriate threshold 
for having their limb amputated, as opposed to ulceration, gangrene, or when their physician stated 
that limb salvage was no longer possible.” 
“I definitely would have had the amputation at the same time point. My pain got so bad, I could not 
walk.” (25) 
Rest pain was also reported to be particularly troublesome during the night causing sleep 
disturbances. Patients had to adapt their position to deal with this pain. Some reported sleeping in a 
chair to overcome the severity of this pain. 
“Experiences such as being forced to sit in a chair during the nights to stand the pain contributed to 
tiredness and feelings of exhaustion.” (17) 
“The greatest beneﬁts of revascularisations were the relief from pain, the ability to sleep again.” (18) 
 
Patients with failed revascularisation and subsequent amputation reported pain at the site of 
amputated limb; however, the phantom pain experienced was tolerable compared to the ischaemic 
rest pain (22). Furthermore, patients who underwent revascularisation complained of some residual 
pain following the procedure. Participants in one study reported that they avoided exercise following 
their intervention and some believed that the pain on walking was an indication that activity causes 




Participants in five studies (15-17, 20, 21) reported altered sensation in the affected limb; these 
symptoms were experienced by patients prior to and following the procedures. The description of this 
altered sensation ranged from feeling “a dead weight”, especially in patients with CLI (15), to a minor 
intermittent tingling feeling in patients with IC (21). Altered sensation secondary to revascularisation 
was caused by either nerve damage or swelling post interventions (16).  
Cold Extremities 
 
Patients with chronic severe lower limb ischaemia complained of cold feet and legs; some of these 
patients reported that despite revascularisation the symptom persisted (18). One participant described 
this symptom in the following terms: 
“I can get up and walk a little and so on. Yes, I have to live with it. It’s sleeping now here and it gets 
cold, like, but when I’m moving the circulation is better. So I see that I’m never going to get rid of it but 
I can live with it because it doesn’t hurt in that way that it did before the operation.” (18) 
In one study some participants experienced coldness in the affected limb pre-operatively, 
postoperatively and after discharge, however, it was worse before revascularisation (15). 
Weakness & Fatigue 
 
Weakness and fatigue was reported by participants in four studies (16, 17, 19, and 20). Some 
reported this symptom to be the first they experienced; describing fatigue on walking followed by pain 
and cramps the more they continued to walk (16, 19). Some experienced loss of power with 
worsening fatigue as the disease progressed and many complained that despite intervention the 
fatigue symptoms did not completely resolve. One patient described this this symptom in the following 
terms: 
“Yes, it’s just like it has taken the strength and power from me..” (17) 
Many patients described that PAD meant living with long term fatigue and powerlessness (17, 20). 
Mobility  
 
Mobility problems were found to be the most significant issue for PAD patients in all of the included 
studies. All the included studies in this review highlighted problems with mobility to be the most 
important issue experienced by patients with PAD. The impact on mobility differed per the type of 
symptoms experienced, and the severity of the disease.  The impact was worse in patients with CLI 
and amputees. Patients with IC reported reducing their walking to avoid the symptoms of pain. IC 
patients also reported employing specific strategies to avoid pain and discomfort on walking by 
stopping regularly, or avoiding walking uphill or upstairs (19-21).  
 
“It depends completely on how hard I walk. If I walk very slowly, I can go many, many blocks, more 
than a dozen, or so. If I walk aggressively, I can start to feel something in maybe two blocks.” (21) 
“I usually shy away from places where I won’t be able to sit down and rest.” (21) 
 
Another patient reported:  
‘‘You know hills and stairs; they’re the worst. And carrying things up the stairs is even worse” (19) 
 
Patients with CLI felt that their personal independence was compromised due to their problems with 
mobility.  They felt the disease took away their ability to walk completely or reduced their walking 
ability. This meant for many of them limited daily activities such as housework, shopping and cleaning 
(17).   
Many patients used aids such as walking sticks, walking frames and sometimes wheelchairs to 
overcome issues with mobility; these changes occurred over a long time to adjust to the symptoms 
(18).  
Many patients with amputation secondary to PAD reported that problems with mobility had the biggest 
impact on their quality of life. The major issues with mobility included maintaining their balance, 
walking upstairs or up ramps. Most patients with amputations relied on using wheelchairs, even if they 
had prosthesis. Many also reported that they wished that they had met the prosthesis specialists prior 
to amputation, to prepare them for life after amputation (22). 
Non-healing ulcers 
 
One of the most distressing symptoms experienced by patients with CLI was non-healing ulcers or 
wounds. Patients used terms like ‘painful’ and ‘disgusting’ to describe their ulcers. Many were 
concerned about the shape and colour of their leg; the shape of the ulcer had an impact on the type of 
clothes and shoes they can wear. Several patients also complained of recurrent leg ulcers due to 
PAD. 
“It’s troublesome because it runs. That’s the hard thing and sometimes it hurts. It’s hard to wear 
shoes.” (17) 
“Well, the district nurse came and looked at it and bandaged it. Then it was all right and then it came 
back, and then it was all right and then it came back again, so it is there now.” (17) 
Sexual functioning  
 
Some patients described a decline in their sexual functioning due to PAD. Although only a minority of 
patients reported that this was important to their overall quality of life. The decline in sexual function 
was associated with progression of symptoms of disease (22).    
Symptom Progression  
 
Participants in four studies understood that PAD is a chronic condition and that it can get worse (17, 
18 20, 21), some reported that they are focusing on avoiding progression of symptoms and worsening 
of PAD. Many patients’ post-intervention adopted new strategies to avoid further intervention by 
modifying their lifestyle and giving up causative agents such as smoking (18). The perception of the 
amount of control participants had over their disease progression varied considerably across the 
studies. These perceptions ranged from having little or none, to having a great deal of control (20). 
Impact on Physical Functioning   
 
Participants in all the included studies described varying impacts on their ability to care for themselves 
independently (15-22), participate in exercise or perform their daily activities. The symptoms of pain 
and reduced mobility had the main impact on physical functioning (22). Patients with severe lower 
limb ischaemia also suggested that their physical function was affected by a lack of sleep due to their 
PAD symptoms, in addition to pain at rest or walking. (20).  
Impact of PAD on Social Functioning   
 
Seven studies described the impact of PAD impact on social life. Many patients reported that their 
social life was compromised including not being able to maintain their personal role, lack of support 
from their social circle, isolation and the inability to perform their hobbies. Problems with isolation and 
lack of social support were worse among patients with amputation secondary to PAD; many of these 
patients felt that a social support group may improve their quality of life (22). Patients with IC and CLI 
felt that their symptoms prevented them from keeping their hobbies, visiting family and friends and 
taking part in many activities that they enjoyed (15-21).  
Psychological Impact of PAD  
 
The papers reported that patients felt they had no control over their disease. This feeling was more 
common amongst patients who had revascularisation but still had some residual symptoms, or those 
that developed complications (16). Many patients suffered from low self-esteem, and felt embarrassed 
because of their symptoms; for example, some participants described feeling embarrassed because 
they stopped frequently to ease the pain. Some reported making up excuses to stop, for example 
pretending to be waiting for someone (19). Patients also suffered with issues of personal image and 
self-perception, with some patients feeling “old before their time.” (19). Patients also reported the 
emotional burden of PAD with many experiencing low mood and a sense of loss due to the disease or 
its complications (16-21). Patients also reported symptoms of anxiety caused by fear of loss of 
independence, fear of amputation or fear of death (15-18, 20-22). 
Financial Impact of PAD  
 
One study described the impact of the disease on participants’ employment, and their ability to carry 
out their tasks at work. Many participants in that study thought that these limitations may lead to job 
loss or the loss of opportunity to be promoted. Some patients planned to change jobs due to their new 
symptoms. (20).   
Process of Care 
 
 
All the studies reported that patients had limited understanding about the consequences of surgery. 
Patients with a diagnosis of IC and no intervention were not clear about their management, and did 
not understand why they were not offered interventions (15, 16). Many patients did not view walking 
as therapy for their disease, and therefore avoided walking as they believed the claudication pain was 
a sign of damage caused to the leg by walking (16).   
Many patients attempted to change their habits and devised strategies to manage their symptoms; 
this included alterations in walking by controlling pace, as well as planning stops for longer walks and 
taking pain relief (15, 16, 19). However, side effects of pain relief medications were a cause for 
restricted use (17). Some participants wished that their risk factors were modified earlier in the 
community including help to give up smoking (20).   
Post-amputation many participants felt that intolerable severe continuous ischaemic rest pain was the 
most appropriate threshold for amputation and saw no point in the revascularisation attempts at that 
stage. On patient said: 
“Most people would try anything to save the leg.” (22) 
“I definitely would have had the amputation at the same time point. My pain got so bad, I could not 
walk.” (22) 
Patients with amputations also reported that meeting with the prosthetics specialists, and spending 
some time familiarising themselves with the rehabilitation services available, prior to the amputation 
would have helped their recovery (22). 
 
Three main subthemes emerged in relation to shared decision making in this review; these were lack 
of knowledge, expectations and communication barriers. 
Several patients reported lack of information about the disease and its progress (16).  Exercise 
therapy was recommended for some patients with claudication or post-operatively, however, patients 
did not understand the importance and relevance of this therapy, and some decided to do the 
opposite and avoid walking (15, 16, 17).  This was mainly because of communication barriers 
between clinicians and patients. 
“When I was in the last time he (surgeon) was talking to a lady doctor and he said I was needing more 
but he started talking funny words that I did not understand.” (16) 
 
“While I was told I had artery disease, I wasn’t told that I could lose my leg. I would have taken better 
care of myself.” (22) 
 
However, sometime this was because of lack of engagement by the patients and handing control over 
decision-making to the clinicians.  
“The likes of [surgeons], they know what they are talking about, they don’t say things unless they are 
sure so I accept what they want to do.” (15) 
 
Patient expectation was also a significant issue. Some had no knowledge of the overall impact of the 
atherosclerosis on their health generally, and others expected the intervention to fully cure the 
disease. Although most patients reported satisfaction with their intervention some were disappointed 
with the results post-operatively as they expected to be back to their pre-disease state with no 
symptoms or disability (15-16, 18, 22). 
Triangulation 
The identified themes were compared to items from validated PROMs that were identified in a recent 
study (8). These PROMs include peripheral artery disease quality of life questionnaire (PADQOL), 
vascular quality of life questionnaire (VascuQoL), Australian vascular quality of life index 
(AUSVIQUOL), peripheral artery questionnaire (PAQ), Intermittent claudication questionnaire (ICQ), 
walking impairment questionnaire (WIQ), EuroQoL-5D (EQ-5D-3L), Nottingham health profile (NHP) 
and Medical outcomes study 36-item short form (SF-36 ®). Two reviewers examined the overlap 
between the themes in the qualitative review and items in the validated PROMs; when there was 
complete overlap between the theme and an item in a PROMs an agreement score (+) was awarded; 
however, when the theme is covered in a general question a partial agreement score was awarded 
(+/-). For instance, EQ-5D has a domain about pain, this domain overlaps completely (is in agreement 
(+)) with the pain theme; the same domain overlaps with themes such as pain on walking, rest pain, 
night pain and phantom pain; although this domain in EQ-5D-3L does not ask about them specifically. 
When the theme is not covered at all a silence score (-) was awarded; for example, in EQ-5D-3L there 
is no questions about sexual functioning or altered sensation.  
The best generic PROMs that captured all the important issues for patients with PAD was the NHP 
and the disease specific PROMs with the best fit with the themes from the qualitative review was the 
VascuQoL. However, VascuQoL did not cover issues important to patients who had an amputation 
secondary to PAD.  
WIQ only covered important symptoms, whereas ICQ only covered some of the themes important to 
patients with intermittent claudication. For further details on the results of triangulation see table 4. 




We identified thirty-five themes associated with quality of life for those with different forms of PAD. 
These themes were divided into six groups: symptoms, physical functioning, impact on social 
functioning, psychological impact, financial impact and process of care 
Measuring quality of life for people with PAD including patients with IC, CLI and amputation is of 
interest currently because of the introduction of new treatment modalities such as drug eluting stents 
and drug coated balloon angioplasty, as well as emerging evidence from trials comparing bypass 
operation to endovascular therapies.   Outcome measures, such as limb salvage, patient survival, 
patency of bypass or vascularised artery, and re-intervention rates, have been used to compare 
outcomes between therapies for patients with PAD, and to inform decision making for patients with 
PAD. However, quality of life and functional status is what matters the most to patients (23, 24).  
 
One of the strengths of this study is that the qualitative review included studies of patients with 
different manifestations of PAD, as PAD can present with a spectrum of symptoms, and with varying 
severity. The inclusion in the review of patients with IC, CLI and amputation ensured that the variation 
of impacts on QoL were captured. This is important due to the complexity of PAD presentation, since 
patients could have IC or CLI or had an amputation in one leg and suffer from a different stage of the 
disease in the other leg. Validated PROMs in this field cover only a stage of the disease.  A 
comprehensive measure can be used to examine the outcomes of patients at different stages of the 
disease.  
 
This review incorporated evidence from a previous systematic review (8) also conducted by the same 
research team, which identified PROMs validated for use with patients with PAD. In the triangulation 
section of this study the themes from this qualitative review were mapped against the domains from 
the validated generic and disease specific PAD PROMs that were identified in the separate review.  
 
The main limitations of this study are that some of the included papers in the qualitative review did not 
specify the severity of PAD in the patients included.  In other studies, the investigators reported the 
severity but did not distinguish between the themes based on the type of PAD. Furthermore, there 
was only one study that reported on the quality of life of patients with PAD related amputation.   
 
The review identified the important symptoms from the patients’ perspective, these included pain, 
altered sensation, cold extremities, fatigue/weakness, issues of mobility, ulcers, sexual functioning 
and symptom progression.  This study also revealed that patients with critical ischaemia and 
intermittent claudication post-intervention complained from some of these symptoms with varying 
degree. Furthermore, many patients with critical ischaemia expressed their views that quality of life 
and severity of symptoms should be considered when deciding the timing and type of intervention 
whether that is revascularisation or amputation.   
 
Amongst some academic and clinical circles quality of life has confusingly come to be known as 
anything which is not clinical (25). However, this review indicates that, when patients with PAD are 
asked, the distress related to symptoms is integral to their quality of life, and in some instances seeing 
beyond the distress of pain and lack of mobility is difficult. The type of pain, its onset, as well as 
location, was different depending on the severity of disease; the same applied to fatigue, weakness, 
altered sensation and mobility. Mobility issues were different between a patient post amputation, and 
someone with claudication; however, the issue remained relevant to both groups. 
 
Issues relating to impact on psychological wellbeing included the following subthemes: lack of control 
over life, negative impact on self-esteem, self- perception, impact on mood, fear of amputation, loss of 
independence and death. The impact of these problems differed between patients depending on the 
whether they suffered with claudication symptoms only, if they had severe ischaemia, or if they had 
undergone an amputation.  
 
One of the strongest finding of this study is that when the themes generated from the review were 
mapped against the generic and disease specific PROMs validated in patients with PAD, none of 
them covered all the important issues revealed by the review. This is likely because the review 
included studies that interviewed patients with IC, CLI  and PAD related amputations; therefore 
including all the themes important to patients with symptomatic PAD.  This provides important 
evidence for critically examining the content of PROMs currently being used in patients with PAD and 
particularly the generic measures such as EQ-5D-3L and SF-36.   
 
Both PROMs are used commonly to inform resource allocation decisions as well monitoring quality of 
life. There are several concerns with generic PROMS for instance EQ-5D-3L & SF-36 were designed 
by experts with no input from patients with PAD and their coverage does not include all the important 
issues to patients with IC, CLI and amputation secondary to PAD. The EQ-5D-3L has five dimensions 
of health: mobility, self-care, usual activities, pain and discomfort, and depression and anxiety. 
Respondents are asked to report their level of problems (no problems, slight/moderate problems or 
severe/extreme problem) on each dimension to provide an overall score for the health state. A key 
concern raised about this measure is the focus on physical health with little focus of psychological 
wellbeing.  
 
The findings of this study can help to provide useful evidence for examining the content validity of 
different measures. This evidence can be used alongside quantitative psychometric evidence to 
design a new disease specific measure. Our group designed this instrument and aim to perform factor 
analysis and well as further psychometric analysis in a large survey of patients with PAD. 
 
 
“Data Availability Statement” 
The analysis data cannot be shared since some of the papers included in the systematic review have 
copy rights and these prohibit publishing them in other journals but allow researchers to use them for 
secondary analysis. These papers were uploaded into the software in which we performed the 
analysis. Supplementary materials are included regarding the search strategy and analysis.  
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